IL147562A0 - Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins - Google Patents

Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Info

Publication number
IL147562A0
IL147562A0 IL14756200A IL14756200A IL147562A0 IL 147562 A0 IL147562 A0 IL 147562A0 IL 14756200 A IL14756200 A IL 14756200A IL 14756200 A IL14756200 A IL 14756200A IL 147562 A0 IL147562 A0 IL 147562A0
Authority
IL
Israel
Prior art keywords
avermectins
ratio
streptomyces avermitilis
gene directing
avermitilis gene
Prior art date
Application number
IL14756200A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL147562A0 publication Critical patent/IL147562A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL14756200A 1999-08-12 2000-07-19 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins IL147562A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
PCT/IB2000/000996 WO2001012822A1 (en) 1999-08-12 2000-07-19 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (1)

Publication Number Publication Date
IL147562A0 true IL147562A0 (en) 2002-08-14

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14756200A IL147562A0 (en) 1999-08-12 2000-07-19 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Country Status (37)

Country Link
US (8) US6248579B1 (sh)
EP (1) EP1200605B1 (sh)
JP (2) JP3688640B2 (sh)
KR (1) KR100486006B1 (sh)
CN (1) CN1186447C (sh)
AP (2) AP2002002417A0 (sh)
AR (1) AR021450A1 (sh)
AT (1) ATE283363T1 (sh)
AU (1) AU779756B2 (sh)
BG (1) BG106478A (sh)
BR (1) BR0013093A (sh)
CA (1) CA2381427A1 (sh)
CO (1) CO5290296A1 (sh)
CZ (1) CZ2002297A3 (sh)
DE (1) DE60016231T2 (sh)
EA (1) EA004569B1 (sh)
ES (1) ES2231214T3 (sh)
GT (2) GT200000138CA (sh)
HK (1) HK1046536B (sh)
HR (1) HRP20020131A2 (sh)
HU (1) HUP0202517A2 (sh)
IL (1) IL147562A0 (sh)
IS (1) IS6249A (sh)
MA (1) MA26811A1 (sh)
MX (1) MXPA02001514A (sh)
NO (1) NO20020665D0 (sh)
OA (1) OA11997A (sh)
PA (1) PA8499201A1 (sh)
PE (1) PE20010697A1 (sh)
PL (1) PL353770A1 (sh)
PT (1) PT1200605E (sh)
SK (1) SK1382002A3 (sh)
TN (1) TNSN00170A1 (sh)
UY (1) UY26287A1 (sh)
WO (1) WO2001012822A1 (sh)
YU (1) YU8402A (sh)
ZA (1) ZA200201071B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60031126T2 (de) * 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
WO2003065991A2 (en) 2002-02-05 2003-08-14 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
EP1476539B1 (en) 2002-02-12 2009-03-25 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
WO2004067549A2 (de) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
DE3881147T2 (de) 1987-10-23 1993-09-02 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
DE69023036T2 (de) 1989-03-31 1996-06-13 Merck & Co Inc Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
ES2204914T3 (es) 1993-07-30 2004-05-01 Pfizer Inc. Genes que codifican el complejo alfa cetoacido deshidrogenasa de cadena ramificada de streptomyces avermitilis.
KR100186946B1 (ko) * 1993-10-05 1999-04-01 알렌 제이.스피겔 도라멕틴의 구충활성 중간체 및 도라멕틴의 제조방법
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
KR20040099389A (ko) * 1998-02-13 2004-11-26 화이자 프로덕츠 인코포레이티드 스트렙토마이세스 하이그로스코피쿠스 유전자

Also Published As

Publication number Publication date
KR20020022809A (ko) 2002-03-27
SK1382002A3 (en) 2002-11-06
US6833263B2 (en) 2004-12-21
UY26287A1 (es) 2001-03-16
NO20020665L (no) 2002-02-11
AU5702100A (en) 2001-03-13
US20010016350A1 (en) 2001-08-23
CO5290296A1 (es) 2003-06-27
US6511841B2 (en) 2003-01-28
DE60016231D1 (de) 2004-12-30
AU779756B2 (en) 2005-02-10
TNSN00170A1 (fr) 2005-11-10
US20030124607A1 (en) 2003-07-03
PE20010697A1 (es) 2001-07-05
CA2381427A1 (en) 2001-02-22
BR0013093A (pt) 2002-08-13
GT200000138CA (es) 2002-02-02
US7029887B2 (en) 2006-04-18
MA26811A1 (fr) 2004-12-20
KR100486006B1 (ko) 2005-05-03
CN1186447C (zh) 2005-01-26
PT1200605E (pt) 2005-04-29
US20010024818A1 (en) 2001-09-27
WO2001012822A1 (en) 2001-02-22
AP2002002419A0 (en) 2002-03-31
US20030129635A1 (en) 2003-07-10
US20030134313A1 (en) 2003-07-17
US20050196777A1 (en) 2005-09-08
US7259241B2 (en) 2007-08-21
US6248579B1 (en) 2001-06-19
GT200000138A (es) 2002-02-02
HUP0202517A2 (hu) 2002-11-28
JP2003507018A (ja) 2003-02-25
AP2002002417A0 (en) 2002-03-31
NO20020665D0 (no) 2002-02-11
US20030129636A1 (en) 2003-07-10
EA200200057A1 (ru) 2002-06-27
AR021450A1 (es) 2002-07-17
OA11997A (en) 2006-04-18
EP1200605A1 (en) 2002-05-02
US6509159B2 (en) 2003-01-21
CN1370239A (zh) 2002-09-18
ZA200201071B (en) 2003-06-25
PA8499201A1 (es) 2001-12-14
JP3688640B2 (ja) 2005-08-31
DE60016231T2 (de) 2005-12-08
MXPA02001514A (es) 2002-07-02
CZ2002297A3 (cs) 2002-08-14
EP1200605B1 (en) 2004-11-24
YU8402A (sh) 2006-03-03
IS6249A (is) 2002-01-25
HK1046536B (zh) 2005-05-13
PL353770A1 (en) 2003-12-01
HK1046536A1 (en) 2003-01-17
BG106478A (bg) 2004-02-27
ES2231214T3 (es) 2005-05-16
EA004569B1 (ru) 2004-06-24
JP2005198658A (ja) 2005-07-28
ATE283363T1 (de) 2004-12-15
HRP20020131A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
EP1363925B8 (en) Macrolide antibiotics
AU2002217277A1 (en) Macrolide antibiotics
HK1042707A1 (zh) 酮內酯類抗生素
AU2001278694A1 (en) Avermectin derivatives
HK1168383A1 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
HU9903073D0 (en) Streptomyces avermitilis regulatory genes for increased avermectin production
IL147562A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
IL137610A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
IL147563A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
AU5789001A (en) Macrolide antiinfective agents
HK1045698A1 (zh) 阿維菌素衍生物
EP1206477A4 (en) CLONING OF THE STREPTOMYCES AVERMITILIS GENES FOR THE GLYCOSYLATION OF AVERMECTIN AGLYCONES
AU1974900A (en) Macrolide intermediates in the preparation of clarithromycin
AU2690500A (en) Avermectin aglycon synthase genes
AU2001277712A1 (en) Avermectin derivatives
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner